CoreLine Soft Co

CoreLine Soft Co EBITDA Growth YoY

The Year-over-Year EBITDA Growth of CoreLine Soft Co (384470.KQ) as of Oct 17, 2026 is -22.06 %. In the previous year, Year-over-Year EBITDA Growth was -15.73 % — a change of 40.20% (lower).

EBITDA Growth YoY

-22.06 %

YoY

40.20%

Last updated:

Year-over-Year EBITDA Growth of CoreLine Soft Co is 2024 -22.06 % . Year-over-Year EBITDA Growth of CoreLine Soft Co was 2023 -15.73 % . It decreases by 40.20% lower compared to the previous year.

The CoreLine Soft Co EBITDA Growth YoY history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Growth YoY
Date
EBITDA Growth YoY
Jan 1, 2021
-121.15 KRW
Jan 1, 2022
-35.62 KRW
Jan 1, 2023
-15.73 KRW
Jan 1, 2024
-22.06 KRW
The CoreLine Soft Co EBITDA Growth YoY history
YEAREBITDA Growth YoYYoY
-22.06 %+40.20%
-15.73 %-55.84%
-35.62 %-70.59%
-121.15 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CoreLine Soft Co Stock analysis

What does CoreLine Soft Co do? CoreLine Soft Co Ltd is a South Korean company headquartered in Seoul, operating within the Health Care sector. The company went public on September 18, 2023, with its stock listed under the ticker 384470.KQ and ISIN KR7384470001. CoreLine Soft focuses on the development and supply of medical software, specifically artificial intelligence-based solutions for medical image analysis. Its primary products involve software that assists medical professionals in diagnosis and supports treatment and research through the analysis of computed tomography (CT) images of the chest, head, and neck. The company operates in the Health Care Technology industry, providing technology-driven tools to enhance medical imaging processes. CoreLine Soft's services aim to improve efficiency and accuracy in medical diagnostics by leveraging AI technology. The company's website is https://www.corelinesoft.com, offering further information about its solutions and services. As a newly listed company, CoreLine Soft is positioned within the growing field of health care technology, contributing to advancements in medical imaging analysis through its specialized software offerings. CoreLine Soft Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CoreLine Soft Co stock

Year-over-Year EBITDA Growth of CoreLine Soft Co is -22.06 % in 2024.

On Eulerpool you can find the complete historical development of Year-over-Year EBITDA Growth CoreLine Soft Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA growth measures the percentage change in EBITDA compared to the prior year. It shows changes in operating cash earnings before capital structure effects.

To evaluate Year-over-Year EBITDA Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBITDA Growth.

Year-over-Year EBITDA Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBITDA Growth's CoreLine Soft Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — CoreLine Soft Co

All Key Metrics — CoreLine Soft Co